Founded by a doctor and a team of patient safety experts, Dosium has a clear mission: to reduce avoidable harm from prescribing errors - a widespread yet preventable issue. Medication errors are responsible for over 1,700 preventable deaths in the UK each year - a figure on par with annual road traffic fatalities - so the issue is vital to get under control. 

At the heart of Dosium’s approach is Touchdose, a decision support tool that provides indication-based, patient-specific dosing recommendations directly into clinicians’ hands. It integrates with Electronic Health Records (EHR) and Electronic Prescribing and Medication Administration (EPMA) systems, and draws from the British National Formulary (BNF) and BNF for Children (BNFC). 

Touchdose automatically calculates the right dose for any drug, patient, and indication - including frequency, duration, and route of administration - while incorporating local guidelines in real time. It offers a safer alternative to manual calculations and unregulated apps, and avoids the pitfalls of current systems, many of which rely on excessive alerts.

In real-world use, Touchdose has shown significant impact.

At St Mary’s Hospital, paediatric clinicians using the tool were 83% less likely to make a prescribing error, with error rates dropping from 7.1% to just 1.2%.

Dosium originated at Imperial College London’s Institute of Global Health Innovation, bringing together expertise from trauma, critical care, and frontline practice to design technology that genuinely enhances prescribing safety.